Biodegradable stents in the treatment of biliary strictures after liver transplantation – first experience
Authors:
Alžběta Hujová 1; Jana Jarošová 1; Peter Mačinga 1; Julius Špičák 1; Jiří Froněk 2; Theodor Adla 3; Pavel Taimr 1; Tomáš Hucl 1
Authors‘ workplace:
Klinika hepatogastroenterologie, Institut klinické a experimentální medicíny, Praha
1; Klinika transplantační chirurgie, Institut klinické a experimentální medicíny, Praha
2; Oddělení radiologie, Institut klinické a experimentální medicíny, Praha
3
Published in:
Gastroent Hepatol 2024; 78(4): 286-290
Category:
Clinical and Experimental Gastroenterology: Review Article
doi:
https://doi.org/10.48095/ccgh2024286
Overview
Biliary anastomotic strictures are one of the most common biliary complications in patients after liver transplantation. Biliary complications are associated with higher mortality, morbidity, risk of graft failure and usually require repeated endoscopic interventions with regular stent replacement for treatment. Biodegradable stents are new types of stents made of bio degradable polymers, which may have the main advantage of reducing the number of endoscopic interventions and associated complications. The aim of our article was to describe the cases of two patients after liver transplantation with early biliary anastomotic strictures, which were resolved by endoscopic placement of bio degradable stents. In both cases, endoscopic stent placement was technically feasible and there were no periprocedural or postprocedural complications. The clinical course and fol low-up imaging at 8 months showed regression of the strictures in both patients.
Keywords:
liver transplantation – benign biliary stenoses – bio degradable stent
Sources
Labels
Paediatric gastroenterology Gastroenterology and hepatology SurgeryArticle was published in
Gastroenterology and Hepatology
2024 Issue 4
Most read in this issue
- The most dangerous factors for pancreatitis after ERCP – systematic review with a prevention approach
- First-line Helicobacter pylori empirical treatment in the Czech Republic 2019– 2024) – initial insights from the European registry on H. pylori management (Hp-EuReg)
- Exocrine pancreatic insufficiency – clinical practice in 2024
- The selection from international journals